Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing gemigliptin to dapagliflozin added to metformin (or in diabetes medication–naïve patients) in type 2 diabetes. The study assesses glyc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)
  • Gemigliptin (gemigliptin)

Snippet

Sponsor: LG Chem | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED